Latest Articles
Lena Dunham shares this traumatic experience involving her own father while promoting her new book - primetimer.com
Lena Dunham shares this traumatic experience involving her own father while promoting her new book primetimer.com
Published: April 12, 2026, 12:37 p.m.
Wives, daughters scramble as ICE deportations spread across Central Texas - Austin American-Statesman
Wives, daughters scramble as ICE deportations spread across Central Texas Austin American-Statesman
Published: April 12, 2026, 10:08 a.m.
The NHS has a women problem - Spiked
The NHS has a women problem Spiked
Published: April 12, 2026, 9:55 a.m.
Get the Xreal One Pro AR Glasses for $170 less at Amazon - Mashable
Get the Xreal One Pro AR Glasses for $170 less at Amazon Mashable
Published: April 11, 2026, 8:13 p.m.
Apple AirTags have never been cheaper — score $15 trackers in Amazon's Spring Sale - Mashable
Apple AirTags have never been cheaper — score $15 trackers in Amazon's Spring Sale Mashable
Published: April 11, 2026, 8:13 p.m.
Spotify Premium: Get three months free - Mashable
Spotify Premium: Get three months free Mashable
Published: April 11, 2026, 8:13 p.m.
Early Prime Day deal: Fire TV gaming bundle under $100 - Mashable
Early Prime Day deal: Fire TV gaming bundle under $100 Mashable
Published: April 11, 2026, 8:13 p.m.
Trastuzumab Pamirtecan Elicits Responses in HER2-Expressing Advanced/Metastatic Endometrial Cancer - OncLive
Trastuzumab Pamirtecan Elicits Responses in HER2-Expressing Advanced/Metastatic Endometrial Cancer OncLive
Published: April 11, 2026, 6:14 p.m.
BioNTech's Trastuzumab Pamirtecan Achieves Positive Phase 2 Results in Advanced HER2-Expressing Endometrial Cancer - Quiver Quantitative
BioNTech's Trastuzumab Pamirtecan Achieves Positive Phase 2 Results in Advanced HER2-Expressing Endometrial Cancer Quiver Quantitative
Published: April 11, 2026, 11:10 a.m.
BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer - The Manila Times
BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer The Manila Times
Published: April 11, 2026, 11:01 a.m.
Link copied to clipboard!